The (pro)renin receptor: A new addition to the renin-angiotensin system?

European Journal of Pharmacology

Volumn 585, Issue 2-3, 2008, Pages 320-324

  Batenburg, Wendy W ^a   Jan Danser, A H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angiotensin; Diabetes; MAP kinase; Nephropathy; Prorenin; Receptor; Renin; Signalling; Transgenic animal

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; PRORENIN; RENIN; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

DIABETES MELLITUS; DRUG ACTIVITY; DRUG INHIBITION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HYPERTENSION; KIDNEY FIBROSIS; MICROANGIOPATHY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSINS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DIABETES MELLITUS; HUMANS; RECEPTORS, CELL SURFACE; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 43049090108     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.092     Document Type: Review

References (57)

1. Amsterdam A., Nissen R.M., Sun Z., Swindell E.C., Farrington S., and Hopkins N. Identification of 315 genes essential for early zebrafish development. Proc. Natl. Acad. Sci. U S A 101 (2004) 12792-12797
2. Bader M. The second life of the (pro)renin receptor. J. Renin Angiotensin Aldosterone Syst. 8 (2007) 205-208
3. Batenburg W.W., Garrelds I.M., Bernasconi C.C., Juillerat-Jeanneret L., van Kats J.P., Saxena P.R., and Danser A.H.J. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation 109 (2004) 2296-2301
4. Batenburg W.W., Krop M., Garrelds I.M., de Vries R., de Bruin R.J.A., Burcklé C.A., Müller D.N., Bader M., Nguyen G., and Danser A.H.J. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J. Hypertens. 25 (2007) 2441-2453
5. Berka J.L., Stubbs A.J., Wang D.Z., DiNicolantonio R., Alcorn D., Campbell D.J., and Skinner S.L. Renin-containing Müller cells of the retina display endocrine features. Invest. Ophthalmol. Vis. Sci. 36 (1995) 1450-1458
6. Burcklé C., and Bader M. Prorenin and its ancient receptor. Hypertension 48 (2006) 549-551
7. Burcklé C.A., Danser A.H.J., Müller D.N., Garrelds I.M., Gasc J.M., Popova E., Plehm R., Peters J., Bader M., and Nguyen G. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 47 (2006) 552-556
8. Danser A.H.J., and Deinum J. Renin, prorenin and the putative (pro)renin receptor. Hypertension 46 (2005) 1069-1076
9. Danser A.H.J., Derkx F.H.M., Schalekamp M.A.D.H., Hense H.W., Riegger G.A.J., and Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J. Hypertens. 16 (1998) 853-862
10. Danser A.H.J., van den Dorpel M.A., Deinum J., Derkx F.H.M., Franken A.A., Peperkamp E., de Jong P.T., and Schalekamp M.A.D.H. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J. Clin. Endocrinol. Metab. 68 (1989) 160-167
11. Danser A.H.J., van Kats J.P., Admiraal P.J.J., Derkx F.H.M., Lamers J.M.J., Verdouw P.D., Saxena P.R., and Schalekamp M.A.D.H. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 24 (1994) 37-48
12. Danser A.H.J., van Kesteren C.A.M., Bax W.A., Tavenier M., Derkx F.H.M., Saxena P.R., and Schalekamp M.A.D.H. Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding. Circulation 96 (1997) 220-226
13. Deinum J., Ronn B., Mathiesen E., Derkx F.H.M., Hop W.C., and Schalekamp M.A.D.H. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia 42 (1999) 1006-1010
14. Feldt S., Batenburg W.W., Mazak I., Maschke U., Wellner M., Kvakan H., Dechend R., Fiebeler A., Burckle C., Contrepas A., Danser A.H.J., Bader M., Nguyen G., Luft F.C., and Müller D.N. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension 51 (2008) 682-688
15. Feldt S., Maschke U., Dechend R., Luft F.C., and Müller D.N. Role of the (pro)renin receptor in transgenic rats with human renin hypertension. J. Am. Soc. Nephrol. 19 (2008) 743-748
16. Huang Y., Noble N.A., Zhang J., Xu C., and Border W.A. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 72 (2007) 45-52
17. Huang Y., Wongamorntham S., Kasting J., McQuillan D., Owens R.T., Yu L., Noble N.A., and Border W. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 69 (2006) 105-113
18. Ichihara A., Hayashi M., Kaneshiro Y., Suzuki F., Nakagawa T., Tada Y., Koura Y., Nishiyama A., Okada H., Uddin M.N., Nabi A.H., Ishida Y., Inagami T., and Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J. Clin. Invest. 114 (2004) 1128-1135
19. Ichihara A., Kaneshiro Y., Takemitsu T., Sakoda M., Suzuki F., Nakagawa T., Nishiyama A., Inagami T., and Hayashi M. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 47 (2006) 894-900
20. Ichihara A., Suzuki F., Nakagawa T., Kaneshiro Y., Takemitsu T., Sakoda M., Nabi A.H., Nishiyama A., Sugaya T., Hayashi M., and Inagami T. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J. Am. Soc. Nephrol. 17 (2006) 1950-1961
21. Itskovitz J., Rubattu S., Levron J., and Sealey J.E. Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy. J. Clin. Endocrinol. Metab. 75 (1992) 906-910
22. Kaneshiro Y., Ichihara A., Sakoda M., Takemitsu T., Nabi A.H., Uddin M.N., Nakagawa T., Nishiyama A., Suzuki F., Inagami T., and Itoh H. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J. Am. Soc. Nephrol. 18 (2007) 1789-1795
23. Kaneshiro Y., Ichihara A., Takemitsu T., Sakoda M., Suzuki F., Nakagawa T., Hayashi M., and Inagami T. Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int. 70 (2006) 641-646
24. Katz S.A., Opsahl J.A., Lunzer M.M., Forbis L.M., and Hirsch A.T. Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium. Hypertension 30 (1997) 259-266
25. Krebs C., Hamming I., Sadaghiani S., Steinmetz O.M., Meyer-Schwesinger C., Fehr S., Stahl R.A., Garrelds I.M., Danser A.H.J., van Goor H., Contrepas A., Nguyen G., and Wenzel U. Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int. 72 (2007) 725-730
26. Krop M., de Bruyn J.H.B., Derkx F.H.M., and Danser A.H.J. Renin and prorenin disappearance in humans post-nephrectomy: evidence for binding?. Front. Biosci. 13 (2008) 3931-3939
27. Lenz T., Sealey J.E., Maack T., James G.D., Heinrikson R.L., Marion D., and Laragh J.H. Half-life, hemodynamic, renal, and hormonal effects of prorenin in cynomolgus monkeys. Am. J. Physiol. 260 (1991) R804-R810
28. L'Huillier N., Sharp M.G., Dunbar D.R., and Mullins J.J. On the Relationship between the Renin Receptor and the Vacuolar Proton ATPase Membrane Sector-associated Protein (M8.9) vol. 20 (2006), (Springer) 17-34
29. Loudon M., Bing R.F., Thurston H., and Swales J.D. Arterial wall uptake of renal renin and blood pressure control. Hypertension 5 (1983) 629-634
30. Ludwig J., Kerscher S., Brandt U., Pfeiffer K., Getlawi F., Apps D.K., and Schagger H. Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J. Biol. Chem. 273 (1998) 10939-10947
31. Luetscher J.A., Kraemer F.B., Wilson D.M., Schwartz H.C., and Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N. Engl. J. Med. 312 (1985) 1412-1417
32. Mukhopadhyay A.K., Cobilanschi J., Schulze W., Brunswig-Spickenheier B., and Leidenberger F.A. Human seminal fluid contains significant quantities of prorenin: its correlation with the sperm density. Mol. Cell Endocrinol. 109 (1995) 219-224
33. Nabi A.H., Kageshima A., Uddin M.N., Nakagawa T., Park E.Y., and Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int. J. Mol. Med. 18 (2006) 483-488
34. Nguyen G., Delarue F., Berrou J., Rondeau E., and Sraer J.D. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 50 (1996) 1897-1903
35. Nguyen G., Delarue F., Burcklé C., Bouzhir L., Giller T., and Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109 (2002) 1417-1427
36. Nishi T., and Forgac M. The vacuolar (H+)-ATPases - nature's most versatile proton pumps. Nat. Rev. Mol. Cell. Biol. 3 (2002) 94-103
37. Peters B., Grisk O., Becher B., Wanka H., Kuttler B., Ludemann J., Lorenz G., Rettig R., Mullins J.J., and Peters J. Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis. J. Hypertens. 26 (2008) 102-109
38. Peters J., and Clausmeyer S. Intracellular sorting of renin: cell type specific differences and their consequences. J. Mol. Cell. Cardiol. 34 (2002) 1561-1568
39. Peters J., Farrenkopf R., Clausmeyer S., Zimmer J., Kantachuvesiri S., Sharp M.G., and Mullins J.J. Functional significance of prorenin internalization in the rat heart. Circ. Res. 90 (2002) 1135-1141
40. Prescott G., Silversides D.W., Chiu S.M., and Reudelhuber T.L. Contribution of circulating renin to local synthesis of angiotensin peptides in the heart. Physiol. Genomics 4 (2000) 67-73
41. Saris J.J., Derkx F.H.M., de Bruin R.J.A., Dekkers D.H.W., Lamers J.M.J., Saxena P.R., Schalekamp M.A.D.H., and Danser A.H.J. High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am. J. Physiol. 280 (2001) H1706-H1715
42. Saris J.J., Derkx F.H.M., Lamers J.M.J., Saxena P.R., Schalekamp M.A.D.H., and Danser A.H.J. Cardiomyocytes bind and activate native human prorenin : role of soluble mannose 6-phosphate receptors. Hypertension 37 (2001) 710-715
43. Saris J.J., 't Hoen P.A., Garrelds I.M., Dekkers D.H., den Dunnen J.T., Lamers J.M.J., and Danser A.H.J. Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension 48 (2006) 564-571
44. Saris J.J., van den Eijnden M.M.E.D., Lamers J.M.J., Saxena P.R., Schalekamp M.A.D.H., and Danser A.H.J. Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II. Hypertension 39 (2002) 573-577
45. Schefe J.H., Menk M., Reinemund J., Effertz K., Hobbs R.M., Pandolfi P.P., Ruiz P., Unger T., and Funke-Kaiser H. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ. Res. 99 (2006) 1355-1366
46. Schweda F., Friis U., Wagner C., Skott O., and Kurtz A. Renin release. Physiology (Bethesda) 22 (2007) 310-319
47. Sealey J.E., Glorioso N., Itskovitz J., and Laragh J.H. Prorenin as a reproductive hormone. New form of the renin system. Am. J. Med. 81 (1986) 1041-1046
48. Senbonmatsu T., Saito T., Landon E.J., Watanabe O., Price Jr. E., Roberts R.L., Imboden H., Fitzgerald T.G., Gaffney F.A., and Inagami T. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. Embo. J. 22 (2003) 6471-6482
49. Suzuki F., Hayakawa M., Nakagawa T., Nasir U.M., Ebihara A., Iwasawa A., Ishida Y., Nakamura Y., and Murakami K. Human prorenin has "gate and handle" regions for its non-proteolytic activation. J. Biol. Chem. 278 (2003) 22217-22222
50. Tada M., Takahashi S., Miyano M., and Miyake Y. Tissue-specific regulation of renin-binding protein gene expression in rats. J. Biochem. 112 (1992) 175-182
51. van den Eijnden M.M., Saris J.J., de Bruin R.J.A., de Wit E., Sluiter W., Reudelhuber T.L., Schalekamp M.A.D.H., Derkx F.H.M., and Danser A.H.J. Prorenin accumulation and activation in human endothelial cells: importance of mannose 6-phosphate receptors. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 911-916
52. van Esch J.H.M., Schuijt M.P., Sayed J., Choudhry Y., Walther T., and Danser A.H.J. AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation. Br. J. Pharmacol. 148 (2006) 452-458
53. van Kats J.P., Danser A.H.J., van Meegen J.R., Sassen L.M., Verdouw P.D., and Schalekamp M.A.D.H. Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation 98 (1998) 73-81
54. van Kats J.P., Duncker D.J., Haitsma D.B., Schuijt M.P., Niebuur R., Stubenitsky R., Boomsma F., Schalekamp M.A.D.H., Verdouw P.D., and Danser A.H.J. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 102 (2000) 1556-1563
55. van Kats J.P., Schalekamp M.A.D.H., Verdouw P.D., Duncker D.J., and Danser A.H.J. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int. 60 (2001) 2311-2317
56. van Kesteren C.A.M., Danser A.H.J., Derkx F.H.M., Dekkers D.H.W., Lamers J.M.J., Saxena P.R., and Schalekamp M.A.D.H. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension 30 (1997) 1389-1396
57. Véniant M., Ménard J., Bruneval P., Morley S., Gonzales M.F., and Mullins J. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J. Clin. Invest. 98 (1996) 1966-1970